Annual report pursuant to Section 13 and 15(d)

SIGNIFICANT ACCOUNTING POLICIES (Tables)

v3.23.1
SIGNIFICANT ACCOUNTING POLICIES (Tables)
12 Months Ended
Dec. 31, 2022
SIGNIFICANT ACCOUNTING POLICIES  
Schedule of calculation of weighted average dilutive common shares

The following shares were excluded from the calculation of weighted average dilutive common shares because their inclusion would have been anti-dilutive:

    

For the Years Ended

December 31, 

    

2022

    

2021

Warrants [1]

 

5,122,074

 

5,122,074

Restricted stock units

651,242

100,000

Restricted stock awards

58,336

166,489

Performance share units

219,376

Stock options

 

36,667

 

94,447

 

6,087,695

 

5,483,010

[1] Includes shares underlying warrants that are exercisable into an aggregate of (i) 368,711 shares of common stock, and (ii) five-year warrants to purchase 368,711 shares of common stock at an exercise price of $5.50 per share.